Recombinant Mouse CDH17/Cadherin 17 Protein
Beta LifeScience
SKU/CAT #: BLK-02390P-100UG
Mouse CDH17 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Mouse CDH17/Cadherin 17 Protein
Beta LifeScience
SKU/CAT #: BLK-02390P-100UG
Collections: Other recombinant proteins, Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Mouse CDH17/Cadherin 17 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Phe26-Met786. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q9R100 |
Target Symbol | CDH17/Cadherin 17 |
Synonyms | Cadherin-17; BILL-cadherin; LI-cadherin; P130; Cdh17; CDH16; HPT-1; cadherin-16; FLJ26931; MGC138218; MGC142024 |
Species | Mouse |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Phe26-Met786 |
Mol. Weight | The protein has a predicted MW of 85.4 kDa. Due to glycosylation, the protein migrates to 90-115 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Liver-intestine cadherin (CDH17) has been known to function as a tumor stimulator and diagnostic marker for almost two decades.In vivo studies showed CDH17 knockout resulted in apoptotic PC tumor death through activating caspase-3 activity. Taken together, CDH17 functions as an oncogenic molecule critical to PC growth by regulating tumor apoptosis signaling pathways and CDH17 could be targeted to develop an anti-PC therapeutic approach. |